DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

• 1. 抗C5抗体治疗患有膜增生性肾小球肾炎的患者的剂量和施用 [P] . 中国专利： CN111278857A . 2020-06-12
• 2. 用于治疗具有补体C5多态性的患者的抗C5抗体 [P] . 中国专利： CN109328197A . 2019-02-12
• 3. DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS [P] . 美国专利： US2020262897A1 . 2020-08-20

  机译： 抗C5抗体的剂量和给药方式，用于治疗增生性肺结核患者

• 4. dosage and administration of anti-c5 antibodies for the treatment of patients with membranoproliferative glomerulonephritis [P] . BR112020006692A2 . 2020-10-06

  机译： c5抗体的剂量和给药方式用于治疗膜增生性肾小球肾炎

• 5. Dosage and administration of anti-C5 antibodies for treatment of patients with Membranoproliferative glomerulonephritis [P] . AU2018345625A1 . 2020-04-16

  机译： 抗C5抗体的剂量和给药方式用于治疗膜增生性肾小球肾炎

• 1. Ziprasidone,haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia:A network metaanalysis [J] . Liang Su, Zheng Lu, Shenxun Shi, 综合精神医学（英文） . 2018,第005期
• 2. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents [J] . Giovanni Garini, Landino Allegri, Maria Luisa Carnevali, Nephrology Dialysis Transplantation . 2006,第11期
• 3. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents [J] . Giovanni Garini, Landino Allegri, Maria Luisa Carnevali, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2006,第11期
• 4. High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis (letter) [J] . Ohsawa I, Ohi H, Endo M, Nephron . 1999,第4期
• 5. Lack of response to classic treatment is associated with anti-cyclic citrullinated peptide antibodies but not with drb1-se status in patients with recent-onset rheumatoid arthritis [C] . Manzanares B., Martinez F., Gonzalez R., European Congress of Immunology . 2009
• 6. Anti-glomerular basement membrane glomerulonephritis: Characterization of an epitope, antibody response, and the potential role of IL-4Ralpha in disease progression. [D] . Robertson, Julie Milayna. 2009
• 7. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report [O] . Ayumu Takeno, Masahiro Yamamoto, Masakazu Notsu, 2016
• 8. Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report [O] . 2016

• 1. Differential Treatment for Membranoproliferative Glomerulonephritis with TCM Prescriptions Plus Triptoryph Tablets A Report of 30 Cases [J] . 鞠建伟 ,连业钦 ,薄守波 . 中医杂志：英文版 . 2003,第3期
• 2. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration [J] . Christine M Hunt ,Lauren A Beste ,Elliott Lowy . 世界胃肠病学杂志：英文版 . 2016,第19期
• 3. Reclassification of membranoproliferative glomerulonephritis:Identification of a new GN:C3GN [J] . Maurizio Salvadori ,Giuseppina Rosso . 世界肾病学杂志：英文版 . 2016,第4期
• 4. Safety and Efficacy of Once-Daily Administration of Mycophenolate Mofetil in Kidney Transplant Patients—A New Treatment Option for Non-Adherence [J] . Naotsugu Ichimaru ,Kazuaki Yamanaka ,Taigo Kato . 生物医学工程（英文） . 2014,第10期
• 5. 罕见的自身抗体合并抗-Fyb患者的抗体鉴定及输血治疗 [C] . 陈文珠 ,凤婧 ,朱凯 . 中国医师协会输血分会2013年第七届输血学术年会 . 2013
• 6. 治疗视神经脊髓炎全人源抗C5单链抗体的研究 [A] . 朱文莉 . 2019